Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 389-393, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riches, P. G.
Right arrow Articles by Harrap, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riches, P. G.
Right arrow Articles by Harrap, K. R.

Some Effects of Chlorambucil on the Chromatin of Yoshida Ascites Sarcoma Cells1

Pamela G. Riches and K. R. Harrap

Department of Applied Biochemistry, Chester Beatty Research Institute, Institute of Cancer Research: Royal Cancer Hospital, Fulham Road, London, SW3 6JB, England

Some effects of chlorambucil (Leukeran) on the composition of the chromatin of Yoshida ascites sarcoma cells are described. Chlorambucil treatment of animals carrying a drug-sensitive line of the tumor results in the progressive removal of histone from the chromatin and its replacement by nonhistone protein present in the nucleus. The biosynthesis of histone is inhibited from the outset, while nonhistone protein biosynthesis declines 12 hr after treatment. These effects are related to morphological changes that occur in the nucleus.

1 This work was supported by grants to the Chester Beatty Research Institute (Institute of Cancer Research: Royal Cancer Hospital) from the Medical Research Council and the Cancer Research Campaign.

Received 8/ 3/72. Accepted 11/ 3/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.